101 related articles for article (PubMed ID: 8758511)
1. [Serum smooth muscle antibodies with anti-actin specificity appeared during treatment with interferon alpha].
Grimbert S; Mohib S; Johannet C; Trinchet JC; Beaugrand M
Gastroenterol Clin Biol; 1996; 20(4):404-5. PubMed ID: 8758511
[No Abstract] [Full Text] [Related]
2. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
Tambini R; Quattrini A; Fracassetti O; Nemni R
J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
[No Abstract] [Full Text] [Related]
3. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
Larrey D
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
[No Abstract] [Full Text] [Related]
4. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
[TBL] [Abstract][Full Text] [Related]
6. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
[TBL] [Abstract][Full Text] [Related]
7. [Permanent hypothyroidism after interferon-alpha treatment in chronic hepatitis C].
Fernández Soto ML; Ventosa M; Luna V; Salmerón FJ
Med Clin (Barc); 1996 Jun; 107(2):76-7. PubMed ID: 8753901
[No Abstract] [Full Text] [Related]
8. [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
Gomollón García F; Simón Marco MA; Vela J; García López S; Fuentes Olmo J
An Med Interna; 1996 Sep; 13(9):438-40. PubMed ID: 9132035
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced obsessive-compulsive disorder.
DeRosse P; Szeszko PR; Malhotra AK
Gen Hosp Psychiatry; 2006; 28(4):357-8. PubMed ID: 16814637
[No Abstract] [Full Text] [Related]
11. [A case of ventricular tachycardia occurred during interferon therapy in chronic hepatitis C].
Omae A; Katayama K; Kakiuchi Y; Okada N; Hijioka Y; Nagai Y; Ito Y; Hagiwara H; Kasahara A; Hayashi N
Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1734-5. PubMed ID: 8537730
[No Abstract] [Full Text] [Related]
12. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
[TBL] [Abstract][Full Text] [Related]
13. [Dysthyroidism and interferon-alpha: the withdrawal of interferon should not be systematic].
Chédin P; Cahen-Varsaux J; Demmane S
Gastroenterol Clin Biol; 1995 Apr; 19(4):442-4. PubMed ID: 7672530
[No Abstract] [Full Text] [Related]
14. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
15. Case of mania induced by withdrawal of interferon-alpha in a patient affected by bipolar disorder.
Rossi A; Renzetti D; D'Albenzio L; Gianfelice D; Kalyvoka A; Rinaldi O
Psychiatry Clin Neurosci; 2002 Dec; 56(6):647-8. PubMed ID: 12485309
[No Abstract] [Full Text] [Related]
16. Interferon-induced sarcoidosis.
Doyle MK; Berggren R; Magnus JH
J Clin Rheumatol; 2006 Oct; 12(5):241-8. PubMed ID: 17023810
[TBL] [Abstract][Full Text] [Related]
17. [Lichen planus and hepatitis C. Heterogeneity in the course of 6 cases treated with interferon alpha].
Doutre MS; Couzigou P; Beylot-Barry M; Beylot C; Quinton A
Gastroenterol Clin Biol; 1996; 20(8-9):709-10. PubMed ID: 8977825
[No Abstract] [Full Text] [Related]
18. Immune system homeostasis during acute hepatitis C: viral escape or T-cell regulation?
Perrella A; Borgia G; Perrella O
Hepatology; 2004 Nov; 40(5):1229; author reply 1229-30. PubMed ID: 15486981
[No Abstract] [Full Text] [Related]
19. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial.
Simon DM; Gordon SC; Kaplan MM; Koff RS; Regenstein F; Everson G; Lee YM; Weiner F; Silverman A; Plasse T; Fedorczyk D; Liao MJ
Hepatology; 1997 Feb; 25(2):445-8. PubMed ID: 9021962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
